EICHORCondition: Breast Cancer · Sponsor: SWOG Cancer Research Network
RATIONALE: Drugs used in chemotherapy, such as doxorubicin, cyclophosphamide, and paclitaxel, use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug and giving them after surgery may kill any remaining tumor cells. It is not yet known which combination chemotherapy regimen is more effective in treating resected breast cancer. PURPOSE: This randomized phase III trial is comparing 2 different regimens of combination chemotherapy to see how well they work in treating patients who have undergone surgery for stage I, stage II, or stage III breast cancer.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Regional Medical Center | Anniston, Alabama, United States | — |
| UAB Comprehensive Cancer Center | Birmingham, Alabama, United States | — |
| Providence Cancer Center at Providence Hospital | Mobile, Alabama, United States | — |
| Providence Cancer Center | Anchorage, Alaska, United States | — |
| Mayo Clinic Scottsdale | Scottsdale, Arizona, United States | — |
| Arizona Cancer Center at University of Arizona Health Sciences Center | Tucson, Arizona, United States | — |
| Hembree Mercy Cancer Center at St. Edward Mercy Medical Center | Fort Smith, Arkansas, United States | — |
| Arkansas Cancer Research Center at University of Arkansas for Medical Sciences | Little Rock, Arkansas, United States | — |
| Alta Bates Summit Comprehensive Cancer Center | Berkeley, California, United States | — |
| Peninsula Medical Center | Burlingame, California, United States | — |
| East Bay Radiation Oncology Center | Castro Valley, California, United States | — |
| Valley Medical Oncology Consultants - Castro Valley | Castro Valley, California, United States | — |
+ 530 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT00070564